Stay updated on Benralizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and criteria for a clinical trial on chronic spontaneous urticaria, while retaining some key identifiers like the EudraCT number and collaborator information.SummaryDifference30%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.